Navigation Links
Tomas Ganz, M.D., Ph.D., to present 2014 ASH E. Donnall Thomas Lecture
Date:7/22/2014

(WASHINGTON, July 22, 2014) The American Society of Hematology (ASH) will honor Tomas Ganz, MD, PhD, of the University of California Los Angeles with the 2014 E. Donnall Thomas Lecture for his groundbreaking research in iron homeostasis, including the discovery of the iron-regulatory hormone hepcidin and investigation of its roles in iron metabolism. This award, named after the Nobel Prize Laureate and past Society president E. Donnall Thomas, MD, recognizes pioneering research achievements in hematology that have represented a paradigm shift or significant discovery in the field.

Dr. Ganz will present his lecture, "Iron, Erythropoiesis, and Host Defense: A Mnage Trois," at 9:00 a.m. on Monday, December 8, at the 56th ASH Annual Meeting and Exposition in San Francisco. His lecture will explore the advances in understanding of homeostatic iron regulation and the iron-regulatory responses to the challenges of acute hemorrhage and acute infection. During his lecture, Dr. Ganz will discuss iron deficiency anemia and anemia of inflammation and will expand upon how their frequency may reflect an evolutionary compromise to provide sufficient iron for essential processes while avoiding the tendency of iron to promote microbial infections and cause tissue injury. He will further elucidate insights into several components of iron regulation and response and discuss how the hormone hepcidin is regulated by erythroferrone, interleukin-6, and, to a lesser extent, other cytokines in response to blood loss and infection. Dr. Ganz's lecture will also touch upon how, as understanding of systemic iron homeostasis and its disorders increases, biological targets for diagnostic and therapeutic applications will be identified.

Dr. Ganz has been the leading scientist in the effort to uncover the molecular basis of iron homeostasis and its disorders. He played a pivotal role in the discovery of hepcidin and continues to lead the way in the ongoing exploration of hepcidin's effects, regulation, and mechanism of action in iron metabolism. Dr. Ganz's scientific approach is based on diverse, sophisticated, and elegant experimental approaches, ranging from molecular analysis of gene and protein regulation in cell lines and transgenic mice, to histopathologic studies and assays of samples from human patients and experimental animals.

Dr. Ganz currently serves as Professor of Medicine and Pathology at the University of California Los Angeles (UCLA) where he also serves as Director of the Will Rogers Pulmonary Research Laboratory and Co-Director of the Center for Iron Disorders. He earned his PhD in Applied Physics from the California Institute of Technology and his medical degree from UCLA. After completing both his residency in internal medicine and fellowship in pulmonary medicine at UCLA, Dr. Ganz joined the UCLA Department of Medicine in 1983 and has remained there ever since.

The importance of Dr. Ganz's work is evidenced through the publication of his research in many high-impact journals, his involvement in prominent organizations, and his receipt of several prestigious awards. Dr. Ganz is a past president of the International BioIron Society and the recipient of its 2005 Marcel Simon Award for excellence in the research of genetic hemochromatosis. In 2006 he was elected to the American Association of Physicians. Dr. Ganz is also a past recipient of the UCLA Medical Alumni Association Medical Science Award. For many years he served as an Associate Editor of Blood, the journal of the American Society of Hematology.

"Through his discovery of hepcidin and subsequent study of its mechanism of action, Dr. Ganz has revolutionized the field of iron biology and has transformed the way scientists and clinicians study and treat iron and anemia-related diseases," said 2014 ASH President Linda J. Burns, MD, of the University of Minnesota. "ASH is pleased to be honoring Dr. Ganz for his work that has paved the way for development of new treatments for these disorders."


'/>"/>

Contact: Amanda Szabo
aszabo@hematology.org
202-552-4914
American Society of Hematology
Source:Eurekalert

Related medicine news :

1. Biomarker may identify neuroblastomas with sensitivity to BET bromodomain inhibitors
2. Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture
3. ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement
4. The Cosmetic Medic Announces Grand Opening of New Skin M.D., a Physician-Administered Anti-aging, Skincare, and Weight Loss Practice
5. St. Jude Childrens Research Hospital names James R. Downing, M.D., CEO
6. Barry A. Siegel, M.D., receives 2014 Benedict Cassen Prize for Research in Nuclear Medicine
7. Mathuram Santosham, M.D., receives 2014 Albert B. Sabin Gold Medal Award
8. Molly Carnes, M.D., receives inaugural Linda Joy Pollin Heart Health Leadership Award
9. Francis S. Collins, M.D., Ph.D., to speak at AMP 2014 Annual Meeting
10. BIDMCs Martin Pollak, M.D., elected to National Academy of Sciences
11. Boston Medical Center cardiologist Gary Balady, M.D., receives AHAs Paul Dudley White Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... , ... May 27, 2016 , ... W.S. Badger ... announced today that it has been recognized as one of the best small businesses ... was named as one of nine small businesses providing progressive benefits to new parents ...
(Date:5/27/2016)... NY (PRWEB) , ... May 27, 2016 , ... ... with Mediaplanet to help educate the many who are unaware of the plight ... to aphasia will run within the “Stroke Awareness” campaign. , The link between ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... in the pharmaceutical, medical and food industries. Aside from its GMP accreditation, Validation ... providing proof of successfully certified products, services and staff. , Validation Center is ...
(Date:5/26/2016)... ... May 26, 2016 , ... Intalere, ... members and suppliers for its inaugural Member Conference at the Paris Hotel in ... elevating the operational health of America’s healthcare providers. , The conference was highlighted ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cardiac arrhythmia ... negative impact on long-term patient survival, reports a team of UPMC researchers in ... week in the Journal of Thoracic and Cardiovascular Surgery, provide critical information that ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... May 25, 2016 According to ... Type (3D, 2D, 4D), by Therapeutic Area (Oncology, Cosmeceutical/Plastic ... User (Medical Device Manufacturers, Hospitals/ Clinics) - Forecast to ... Medical Animation Market for the forecast period of 2016 ... 301.3 Million by 2021 from USD 117.3 Million in ...
(Date:5/25/2016)... 25, 2016 According to market ... Growth and Demand Forecast to 2022 - Industry Insights ... Others)" published by P&S Market Research, the global insulin ... 2015, and it is expected to grow at a ... insulin pump segment is expected to witness the fastest ...
(Date:5/25/2016)... England , May 25, 2016 ... company employing the precision of circulating tumour DNA ... today announces the appointment of Professor Clive ... provide medical leadership across the clinical development programme, ... Inivata,s products help deliver significant improvements in clinical ...
Breaking Medicine Technology: